Evidence map›Paper›PMID 26331012›Full record

ArticleClinical case reports2015

Multidisciplinary therapy for granulocyte-colony-stimulating factor producing carcinosarcoma of the esophagus: report of a case.

Shinichiro Kobayashi, Yasuhiro Nagata, Hirotaka Tokai, Masahiro Ito, Hikaru Fujioka

Open access · goldAbstract readCase Reports
In one paragraph

Article in Clinical case reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.7field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Oesophageal carcinosarcoma: a rare neoplasm of the oesophagus.Annals of the Royal College of Surgeons of England · 2023
    Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Shinichiro KobayashiDepartment of Surgery, National Hospital Organization Nagasaki Medical Center Ohmura, Nagasaki, 8568562, Japan.
Yasuhiro NagataDepartment of Surgery, National Hospital Organization Nagasaki Medical Center Ohmura, Nagasaki, 8568562, Japan ; Center for Comprehensive Community Care Education, Nagasaki University Graduate School of Biomedical Sciences Nagasaki, Nagasaki, 8528102, Japan.
Hirotaka TokaiDepartment of Surgery, National Hospital Organization Nagasaki Medical Center Ohmura, Nagasaki, 8568562, Japan.
Masahiro ItoDepartment of Pathology, National Hospital Organization Nagasaki Medical Center Ohmura, Nagasaki, 8568562, Japan.
Hikaru FujiokaDepartment of Surgery, National Hospital Organization Nagasaki Medical Center Ohmura, Nagasaki, 8568562, Japan.
Nagasaki Medical Center · JPNagasaki University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The granulocyte-colony-stimulating factor (G-CSF)-producing esophageal carcinosarcoma is extremely rare in esophageal cancer. In the present case, multidisciplinary therapy, which is surgical resection with preoperative chemotherapy, has been effectively treatment to granulocyte-colony-stimulating factor producing esophageal carcinosarcoma of the esophagus.

Indexed as

Esophageal carcinosarcomagranulocyte-colony-stimulating factorneutrophiliapreoperative chemotherapy

Identifiers

PMID26331012
PMCPMC4551325
OpenAlexW1566518685

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.